21 June 2017
(Journal 6683)
| SPC/GB17/033 | Lodged | Applicant: Intercept Pharmaceuticals, Inc. 10 Hudson Yards, 37th Floor, New York, NY 10001, USA
Product: obeticholic acid
Product Type: Medicinal Authorised: UK EU/1/16/1139 15 December 2016
Authorised Extension:
Patent No: EP1392714 Title: Steroids as agonists for FXR
SPC No: SPC/GB17/033 Date Lodged: 20 May 2017 |